Precision BioSciences (FRA:PBS0) Short-Term Capital Lease Obligation : €1.09 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Precision BioSciences Short-Term Capital Lease Obligation?

Precision BioSciences's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was €1.09 Mil.

Precision BioSciences's quarterly Short-Term Capital Lease Obligation declined from Sep. 2023 (€1.40 Mil) to Dec. 2023 (€1.04 Mil) but then increased from Dec. 2023 (€1.04 Mil) to Mar. 2024 (€1.09 Mil).

Precision BioSciences's annual Short-Term Capital Lease Obligation declined from Dec. 2021 (€1.61 Mil) to Dec. 2022 (€1.58 Mil) and declined from Dec. 2022 (€1.58 Mil) to Dec. 2023 (€1.04 Mil).

Precision BioSciences Short-Term Capital Lease Obligation Historical Data

The historical data trend for Precision BioSciences's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Precision BioSciences Short-Term Capital Lease Obligation Chart

Precision BioSciences Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

1.59

1.61

1.58

1.04

Precision BioSciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															1.96	2.31	1.40	1.04	1.09

Precision BioSciences Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Precision BioSciences Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Precision BioSciences's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Precision BioSciences (FRA:PBS0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Precision BioSciences Inc (FRA:PBS0) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

DTIL:USA

Address

302 East Pettigrew Street, Dibrell Building, Suite A-100, Durham, NC, USA, 27701

Website

https://www.precisionbiosciences.com

Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.

Precision BioSciences (FRA:PBS0) Headlines

No Headlines